Valponol -500 CR combines Sodium Valproate (333 mg) and Valproic Acid (145 mg) in a controlled-release formulation designed for the management of epilepsy and bipolar disorder. Sodium Valproate works by stabilizing electrical activity in the brain while Valproic Acid enhances its therapeutic effects. This combination helps prevent seizures and mood swings making it an effective option for individuals seeking stable control over their condition.
Reviews
There are no reviews yet.